THE PARKINSONS LIBRARY
Explore what researchers are learning about Parkinson’s: what may cause it, how it progresses, and what might help stop it.
A growing collection across languages and research areas. Many records currently contain only publication details or an abstract.
FIND YOUR STARTING POINT
Look up a topic, gene or publication. Narrow the collection by year, language or research focus.
Browse the catalog ↗ 02 / UNDERSTANDFollow the research question, experiment and findings in a short overview or a more detailed story.
Choose a reading ↗ 03 / CONNECTFollow avenues of research through time and discover which topics researchers are studying together.
Open the research map ↗ 04 / COMPAREExplore an early set of extracted findings, including favorable outcomes and results with no clear difference.
Explore the findings ↗START READING
These readings explain acquired full-text papers. AI-authored explanations have not yet been expert-reviewed.
BUILT AROUND THE ORIGINAL RESEARCH
The library brings publications together to help people understand the research and investigate possible connections. Every explanation keeps its source close by.
A result in cells or animals is different from a benefit shown in people. We keep those distinctions visible, along with negative results and unanswered questions. The collection and its automated classifications are still being developed.
A traceable library for exploring Parkinson's mechanisms,
prevention, and the course of disease.
Search what changed, in whom, and under which conditions. A favorable result means improvement on a measured outcome in that experiment; it does not establish a cure or benefit in people.
Open a paper from the catalog, paste its text, or load a PDF. Explore the question, experiment and reported findings with the source beside you.
[Pharmacologico-clinical trials of the association of L-dopa and gamma-hydroxybutyric acid in therapy of Parkinson's disease].
A plain-language reading has not been prepared for this paper yet.
Follow research from earlier publications to recent work. Choose an avenue or a point in time to explore its papers, the teams named in them, and connections to other topics.
These are overlapping topic matches in our collection, not a ranking of treatments or a history of proven discoveries. Collection coverage varies by period and language. A shared topic does not establish a scientific connection.
Read left to right. Each cell shows a publication count; darker shading means a larger share or count. Select any cell to open its papers. Papers can appear in several rows.
Avenues use the catalog’s candidate topic tags plus explicit terms in titles and abstracts, including some historical names and non-English terms. Open “Why this paper appears here” to see a match. Rules are incomplete and can match background discussion or a negative result. No model infers a paper’s findings from its title.
The earliest date shown is the earliest matching publication in this library, not the discovery date. Research groups are shown through the authors on individual papers; names have not been combined into laboratories or disambiguated. Shared-topic counts describe publications, not independent experiments, collaboration or causation. Sparse areas may reflect collection gaps rather than neglected scientific opportunities.
Plain-language explanations of biology, experiment design and statistics. Definitions are editorial drafts, with background references.
Source records can overlap. A language is not an author's country, and a connected source is not an exhaustive collection.
Import UTF-8 RIS, CSV, or Web of Science tagged text. Preview the records before adding them to the library.
Queries, source counts, and checkpoints for every collection run.
This library prioritizes causes, mechanisms of degeneration, prevention, disease modification, and durable restoration. Symptom-management research stays in the collection because useful connections can cross research boundaries.
Five metadata collectors, multilingual discovery, preserved source responses, identifier-based linking, authorized export imports, permitted PMC article text, PDF/text reading guides, a glossary, source-linked plain-English examples, a durable reading queue and an early searchable findings pilot.
Broader licensed access, more full text, trial and dataset links, historical scans, expert review, and broader structured extraction. Study and participant overlap must be assessed before reports can be counted as independent evidence.
Tags are transparent keyword candidates, not an assessment of causality, treatment efficacy, or study quality. A passage saying an approach failed may receive the same topic tag as one reporting success. Open a record to see the words that matched.
This release contains bounded API samples. Absence from the catalog means only that material has not been collected here. Some permitted full texts have been acquired; most records still contain metadata or abstracts. Participant-level data have not been acquired. Original abstract text may carry its own reuse restrictions.